ERBB2 and breast neoplasm: Some authors have shown that HER2 overexpression is the main determinant of increased expression of cyclooxygenase-2 and synthesis of prostaglandin E2 in breast tumor cells, which in turn, leads to increased CYP19A1 gene expression and aromatase activity [34–36].